In Canada’s healthcare sector, mergers and acquisitions (M&A) are growing as consolidation reshapes the industry. For home health and hospice providers, one of the most common questions is: What is my business worth?
The Core Formula
Valuation in healthcare often starts with a simple equation:
Value = Adjusted EBITDA × Valuation Multiple
While the formula looks simple, both variables are complex. Adjusted EBITDA reflects true operating performance after non-recurring expenses are added back. The multiple depends on buyer motivation, synergies, and market dynamics.
Adjusted EBITDA
EBITDA measures profitability, but adjustments (such as removing one-time costs or excess owner expenses) create a clearer picture. Sellers should carefully document addbacks to strengthen valuation during negotiations.
Time Periods Matter
Buyers may calculate EBITDA differently: trailing twelve months (TTM), year-to-date annualized, or shorter trailing periods. Each perspective can shift reported results and, ultimately, valuation.
Valuation Multiples
Multiples in healthcare vary widely, often ranging from 3× to 10× depending on company size, market, and buyer interest. Strategic buyers with strong synergies may justify paying higher multiples, while others apply more conservative metrics.
The Role of Synergies
Unlike addbacks, synergies depend on the buyer. For example, a regional buyer may eliminate redundant overhead, increasing profitability and supporting a higher valuation.
Takeaway for Canadian Owners
Valuation is more than a formula. It reflects performance, timing, and the buyer’s perspective. Understanding these factors and engaging the right buyer can maximize your company’s outcome in a competitive healthcare M&A market.
Aspen Valuations helps Canadian healthcare owners navigate M&A with expertise, ensuring valuations reflect both performance and buyer dynamics.
